Artiva Biotherapeutics, Inc. · NASDAQ:ARTV
Artiva Biotherapeutics, Inc. shareholders
As of Jun 30, 2026, 69 institutions reported holding Artiva Biotherapeutics, Inc., 83.2% of its shares. Largest: Ra Capital Management, L.P., Viking Global Investors LP and Blackstone Inc. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Artiva Biotherapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Ra Capital Management, L.P. | 18M | 36.7% | +8.1M | Aug 14, 2026 |
| Viking Global Investors LP | 2.6M | 5.3% | new | Aug 14, 2026 |
| Blackstone Inc. | 2.4M | 4.9% | new | Aug 14, 2026 |
| 5AM Venture Management, LLC | 2.35M | 4.8% | no change | Aug 14, 2026 |
| Venrock Adviser, LLC | 2.04M | 4.2% | +434K | Aug 14, 2026 |
| Franklin Templeton | 2M | 4.1% | +1.48M | Aug 13, 2026 |
| Caligan Partners LP | 1.74M | 3.6% | new | Aug 14, 2026 |
| Vanguard | 1.17M | 2.4% | +933K | Aug 13, 2026 |
| Samsara Biocapital, LLC | 955K | 2.0% | new | Aug 14, 2026 |
| Blue Owl Capital Holdings LP | 875K | 1.8% | new | Aug 11, 2026 |